Genetic Association of HTR1B and HTR2A Gene Polymorphisms with ADHD in Korean Children and Adolescents: A Case

Yeongsuk Lee1,2, Hyung Jun Kim3, Han Jun Jin3

  • 1Department of Psychiatry, Graduate School, Soonchunhyang University, Asan 31538, Republic of Korea.

Genes
|May 27, 2026
PubMed

Insights

Genetic variations in the HTR2A gene may influence attention-deficit hyperactivity disorder (ADHD) susceptibility. This study found a potential link between HTR2A rs9534495 and ADHD in a Korean sample, though further research is needed.

Area of Science:

  • Neurogenetics
  • Psychiatric Genetics
  • Molecular Psychiatry

Background:

  • Attention-deficit hyperactivity disorder (ADHD) is a common childhood neurodevelopmental disorder.
  • Serotonergic system genes are implicated in ADHD pathophysiology.
  • Investigating specific gene polymorphisms can elucidate ADHD genetic susceptibility.

Purpose of the Study:

  • To examine the association between HTR1B and HTR2A gene polymorphisms and ADHD risk in a Korean population.
  • To identify specific single nucleotide polymorphisms (SNPs) within the serotonergic pathway linked to ADHD.
  • To understand the role of serotonergic system variations in ADHD development.

Main Methods:

  • Case-control study involving 234 children with ADHD and 1686 healthy controls.
  • Genotyping of HTR1B (rs6296) and HTR2A (rs6311, rs6313, rs9534495) SNPs.
  • Statistical analysis using Chi-square tests and odds ratios across different inheritance models.

Main Results:

  • A significant association was found between HTR2A rs9534495 and ADHD under dominant, recessive, and additive models (p < 0.05).
  • These associations did not remain significant after Bonferroni correction.
  • No significant associations were observed for HTR1B rs6296 or other HTR2A SNPs (rs6311, rs6313).

Conclusions:

  • Genetic variations in the HTR2A gene may contribute to ADHD susceptibility.
  • The study highlights potential roles of serotonergic genes in ADHD.
  • Further large-scale, multi-ethnic studies with functional assays are recommended to confirm findings.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Behavioral Genetics and Its Designs01:23

Behavioral Genetics and Its Designs

Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...